Navigation Links
Gastric Bypass And Laparoscopic Reflux Surgery Gaining Popularity

eaths or serious complications. The five-year follow-up of older adults showed an average BMI reduction of 46 to 33 with a 51 percent reduction in obesity-induced diseases and health conditions. In this group, there was a one percent mortality rate, and 15 percent experienced complications.

‘This study reveals that bariatric surgery is a safe and effective option for all ages, including severely obese adolescents and older adults,’ said Michael Sarr, M.D., of the Mayo Clinic and senior study author. ‘The remarkable decrease in BMI lowers the risk of health complications and increase chances for long-term survival for people battling with obesity. For adolescents especially, early treatment of obesity is instrumental in reducing the long-term health complications associated with obesity.’

A Randomized Controlled Trial of Laparoscopic Nissen Fundolplication (LNF) versus Proton Pump Inhibitors for Treatment of Patients with Chronic Gastro-Esophageal Reflux Disease (GERD) [Abstract 256]

Gastroesophageal reflux disease (GERD), a chronic gastrointestinal disease that affects more than seven million people in the United States, is most commonly treated with medication or surgery to manage disease symptoms. Researchers at McMaster University in Ontario conducted a study to evaluate the efficacy of individual versus combined treatment regimens in attempt to further reduce symptoms. Results demonstrated that patients who managed symptoms with a class of medicines called proton pump inhibitors (PPI) and underwent laparoscopic Nissen fundoplication (LNF) experienced a significant reduction in symptoms associated with GERD. Proton pump inhibitors, such as omeprazole and lansoprazole, reduce symptoms and repair erosion to the esophagus by reducing the upswell of acid from the stomach into the esophagus. Doctors perform LNF with a video laparoscope, wrapping the upper part of the stomach around the lower esophagus to strengthen the control valve to de
'"/>




Page: 1 2 3

Related medicine news :

1. The Reason For Loss Of Appetite After Gastric Bypass
2. Gastric bypass surgery reduces risk of heart disease
3. Surgeons Perform Robotic Gastric Bypass Surgery
4. Helicobacter pylori Antibiotic Treatment of Peptic Ulcer May not Prevent Gastric lymphomas
5. New Gastric Cancer Drug Unlikely to Benefit Kidney Cancer Patients
6. Migraine Patients Suffer From Gastric Stasis
7. Gastric bypass can cause deficiency of Vitamin A
8. For Super-Obese Patients, Duodenal Switch Beats Gastric Bypass
9. Long-time Gastric Acid Suppression Does Not Increase The Risk Of Cancer
10. Gastric Bypass Surgery May Lead to Increased Kidney Stone Risk
11. Robotically Assisted Colo-resection And Gastric Bypass Surgeries Are Becoming Popular
Post Your Comments:
Breaking Medicine News(10 mins):Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 2Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 2Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 3Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 4Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 5Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 6Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 7Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 8Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 9Health News:Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference 2Health News:Help Young Cancer Patients Enjoy Christmas This Season 2